Amwill Healthcare IPO
GMP, Subscription, Price, Dates & Financial Details
Amwill Healthcare Limited is a derma-cosmetic development company that focuses on creating dermatological, cosmeceutical, and aesthetic products. The company partners with contract manufacturers, distributors, and third-party development agencies to handle manufacturing, packaging, and…
Open Date
Wed, 05 Feb 2025
Close Date
Fri, 07 Feb 2025
Price Band
₹ 105 – 111
Lot Size
1200
Issue Size
₹ 59.98 Cr
Minimum Investment
₹ 266,400 (2400 Shares)
Grey Market Premium Analysis
Day Wise GMP→Unofficial premium quoted in the grey market, tracked daily against the price band cap.
Grey market trading is unregulated. GMP figures are indicative only and should not be the sole basis for investment decisions - treat as a sentiment indicator, not a guarantee.
IPO Details
Amwill Healthcare IPO has successfully completed its IPO process and is now listed on BSE SME Platform. According to the Red Herring Prospectus (RHP), the IPO was a book-built issue with a total issue size of ₹59.98 Crore, comprising a fresh issue of 44.04 Lakh equity shares aggregating to ₹48.88 Crore and an offer for sale (OFS) of 10.00 Lakh equity shares aggregating to ₹11.10 Crore by the existing shareholders.
The Amwill Healthcare IPO remained open for subscription from February 05, 2025, to February 07, 2025. The basis of allotment was finalized on February 10, 2025, and the company's shares were listed on BSE SME Platform on February 12, 2025.
The company had fixed the price band at ₹105 to ₹111 per share, with a lot size of 1200 shares. Retail investors were required to make a minimum investment of ₹266,400 (based on the upper price band) to apply for one lot.
Bigshare Services Pvt Ltd served as the registrar to the issue. Unistone Capital Pvt Ltd acted as the Book Running Lead Managers (BRLMs) to the issue.
With the successful completion of the IPO process, Amwill Healthcare Limited is now a publicly listed company on BSE SME Platform. Investors can track the company's share price, trading performance, financial results, and corporate announcements through the stock exchanges.
Amwill Healthcare IPO Timeline (Tentative)
- IPO Open Date
- Wed, 05 Feb 25
- IPO Close Date
- Fri, 07 Feb 25
- Basis of Allotment
- Mon, 10 Feb 25
- Initiation of Refunds
- Tue, 11 Feb 25
- Credit of Shares to Demat
- Tue, 11 Feb 25
- Listing Date
- Wed, 12 Feb 25 — NSE & BSE
Open Date
05 February 2025
Close Date
07 February 2025
Basis Of Allotment
10 February 2025
Listing Date
12 February 2025
IPO Subscription
Check Live Subscription →The Amwill Healthcare IPO has received bids for 2,96,83,200 shares against 54,03,600 shares offered, resulting in an overall subscription of 5.49x. the NII category is subscribed 5.12x, Retail Investors 4.77x, and QIBs 7.8x.
QIB
7.8x
NII
5.12x
RII
4.77x
Total
5.49x
IPO Reservations
The Retail Individual Investor (RII) category has the highest allocation with 20,53,200 shares, representing 0% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 10,26,000 shares (0%), while Non-Institutional Investors (NIIs) receive 23,24,400 shares (0%).
| Category | Shares Offered | Shares Offered % |
|---|---|---|
| Qualified Institutions | 1,026,000 | 0% |
| Non-Institutional | 2,324,400 | 0% |
| Retail Investors | 2,053,200 | 0% |
| Total | 5,403,600 | 0% |
Financials Details(₹ in Crores)
| Particular | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 28.89 | 18.98 | 12.39 | 6.59 |
| Revenue | 23.25 | 44.28 | 30.28 | 27.62 |
| Profit After Tax | 6.52 | 12.54 | 3.11 | 2.57 |
| Net Worth | 23.68 | 17.16 | 4.6 | 1.49 |
| Reserve & Surplus | 8.08 | 17.11 | 4.57 | 1.46 |
| Total Borrowings | 0 | 0 | 0 | 0 |
Financials Performance
Performance Indicators
EPS Pre
Earnings per share before the IPO.
P/E Pre
IPO Offer Price ÷ EPS Pre.
EPS Post
Expected earnings per share after the IPO..
P/E (Post Issue)
IPO Offer Price ÷ EPS Post.
Amwill Healthcare Limited KPI Information
| Particular | KPI as of Mar 31, 2023. |
|---|---|
| ROE % | 73.06 |
| ROCE % | 94.16 |
| RoNW % | 73.06 |
| Pat Margin % | 28.53 |
Peers Comparison
No Peer Comparision Available
About Amwill Healthcare Limited
Amwill Healthcare Limited is a derma-cosmetic development company that focuses on creating dermatological, cosmeceutical, and aesthetic products. The company partners with contract manufacturers, distributors, and third-party development agencies to handle manufacturing, packaging, and distribution, enabling it to concentrate on product formulation and development. Its operations are concentrated in Karnataka, Andhra Pradesh, and Telangana, with plans to expand to West Bengal and Odisha.
The company’s product portfolio includes generic dermatological solutions and specialized formulations addressing specific skin problems. Amwill's products are developed with input from dermatologists, and its managing director, Anand Gandhi, has played a significant role in product development. The company has developed several products, though some were discontinued due to lack of market response.
Amwill collaborates with contract manufacturers to ensure quality compliance and leverages third-party developers for active ingredient preparation. Distribution is handled by Amderma Healthcare LLP, a promoter group entity that stores and delivers Amwill’s products to customers.
The company has a structured sales and marketing team, focusing on doctor relationships, exhibitions, and scientific journals to promote its products. The management team has over 20 years of experience in the dermatology industry, providing a competitive edge for the company's growth.
Financially, Amwill has shown significant growth, with a revenue increase from ₹1,799.94 lakhs in FY2021 to ₹3,578.83 lakhs in FY2023. Its EBITDA and profit after tax have also improved, indicating strong financial performance.
Amwill Healthcare IPO Promoters
- Anand Gandhi
- Tarun Gandhi
Promoters Holding
Holding Pre Issue
97.00%
Holding Post Issue
0.00%
Amwill Healthcare IPO Objective
The company proposes to utilize the Net Proceeds in the following manner.
- Funding of working capital requirements of the Company
- Marketing and brand-building activities
- General corporate purposes
Amwill Healthcare Limited Address / Contact Details
Amwill Healthcare Limited
No. 157, 1st Floor, 2nd Main, 3rd
Cross Chamrajpet,
Bangalore – 560018, Karnataka
Phone: +91 8043026281
Email: amwill@amwillhealthcare.com
Website: https://www.amwillhealthcare.com/
IPO Snapshot
Amwill Healthcare IPO Lot Size
The Amwill Healthcare IPO has a lot size of 1,200 shares. Retail investors require a minimum investment of ₹1,33,200 by applying for 1 lot (1,200 shares). The maximum application allowed for the retail category is 1 lots (1,200 shares), requiring an investment of ₹1,33,200.
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | 133,200.00 |
| Retail (Max) | 1 | 1,200 | 133,200.00 |
| S-HNI (Min) | 2 | 2,400 | 266,400.00 |
Issue Reservation
Book Running Lead Managers
- Unistone Capital Pvt Ltd
IPO Documents & Links
Explore More IPOs
Currently Open
Coming Up Next
Disclaimer: This data is for informational purposes only and does not constitute investment advice.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Amwill Healthcare IPO?
Amwill Healthcare IPO is a Book-building IPO with a total issue size of ₹59.98 crore. The Amwill Healthcare IPO price band is ₹105 to 111 per share. The Amwill Healthcare IPO subscription opens on Wed, Feb 5, 2025, and closes on Fri, Feb 7, 2025. The Amwill Healthcare IPO will be listed on the BSE. Bigshare Services Pvt Ltd is the registrar for the Amwill Healthcare IPO.
When will the Amwill Healthcare IPO open for subscription?
The Amwill Healthcare IPO opens on Wed, Feb 5, 2025 and closes on Fri, Feb 7, 2025
What is Amwill Healthcare IPO Price Band?
Amwill Healthcare IPO Price Band is ₹105 to 111 per share.
What is Amwill Healthcare IPO Lot Size?
Amwill Healthcare IPO lot size is 1200 shares, Retail investors need a minimum investment of ₹266400 based on the upper price band
What is the minimum investment for Amwill Healthcare IPO?
The minimum investment for Amwill Healthcare IPO is ₹266400, based on one lot of 1200 shares at the upper price band of ₹111 per share.
How to apply for Amwill Healthcare IPO?
Investors can apply for the Amwill Healthcare IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Feb 7, 2025. The application amount remains blocked until the Amwill Healthcare IPO allotment is finalized.
What is Amwill Healthcare IPO Issue Size?
Amwill Healthcare IPO issue size is ₹59.98 crores.
What is the Amwill Healthcare IPO Allotment Date?
Amwill Healthcare IPO allotment date is Mon, Feb 10, 2025.
Who is the Amwill Healthcare IPO Registrar?
The registrar for Amwill Healthcare IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website to check Amwill Healthcare IPO allotment status, refund processing, and other IPO-related information.
What is the Amwill Healthcare IPO GMP?
The Amwill Healthcare IPO GMP (Grey Market Premium) is ₹3 as of Fri, Feb 7, 2025. Based on the upper price band of ₹111 per share, the estimated Amwill Healthcare IPO listing price is ₹114, indicating a potential listing gain of approximately 2.70% over the issue price.
Who is the Amwill Healthcare IPO Lead Manager?
The book-running lead managers (BRLMs) for the Amwill Healthcare IPO are Unistone Capital Pvt Ltd. The lead managers are responsible for managing the IPO process, including issue structuring, regulatory compliance, marketing the public issue, coordinating with investors, and ensuring a smooth listing process. For complete details, investors should refer to the Amwill Healthcare IPO Red Herring Prospectus (RHP).